The PennZone

  • Home
  • Business
  • Health
  • Construction
  • Financial
  • Automotive
  • Technology
  • Arts
  • Sports

SafeBreak® Vascular Cleared for Pediatrics
The PennZone/10232295

Trending...
  • Turbo vs. Experts: Tracking OddsTrader's AI Performance at the NFL's Midpoint
  • 2026 Oscars Betting Odds: One Battle After Another Favored for Best Picture
  • Emeritus Addresses Hospital Bed Shortages with Smart Storage Solutions
SafeBreak Vascular installed on a pediatric line SafeBreak Vascular installed on a pediatric line SafeBreak Vascular installed on a pediatric line Lineus Medical
FAYETTEVILLE, Ark. - PennZone -- Lineus Medical, a medical device company focused on reducing IV complications, announced that the company's flagship product, SafeBreak Vascular, has received clearance from the U.S. Food and Drug Administration (FDA) for use in pediatric patients. SafeBreak Vascular has been shown in adult clinical studies to reduce IV complications with its innovative breakaway technology1.

SafeBreak Vascular is the first breakaway device cleared by the FDA and proven to reduce IV complications in adults by 44%1. It fits between the IV tubing from the IV pump and the patient's IV access point at the arm. When there is a damaging force on the line, SafeBreak separates to protect the patient's IV. This innovative feature helps prevent accidental dislodgement of the catheter, as well as other IV complications caused by damaging forces on the IV line1. This is especially important for pediatric patients who may be more active, less inclined to follow instructions, and less aware of their surroundings.

More on The PennZone
  • Upcoming Launch of Retail Crypto Cloud Mining Platform with Daily Rewards in a Transparent Revenue-Share Model: iMD Companies, Inc. Stock Symbol: ICBU
  • BumblebeeSmart Introduces Rounded Busy Board Set for Preschoolers
  • CRH Healthcare Opens 100th Urgent Care Clinic with Second Peachtree Immediate Care Location in Covington
  • COHN Named Colorado State-Approved Vendor for Advertising & Marketing Services
  • The Kryder Law Group, LLC Report Reveals Commercial Air Travel Is Safer Than You Think

"We are incredibly proud to receive clearance from the FDA for the use of SafeBreak Vascular with pediatric patients," said Vance Clement, CEO of Lineus Medical. "SafeBreak provides a simple, effective solution for preventing IV complications, which reduces IV restarts and additional needlesticks for patients.  Now, it doesn't matter if the patient is 1 or 100 years old, SafeBreak is cleared for use on all peripheral IVs.  Our goal is to have a SafeBreak on every IV line, everywhere in the world, and this additional clearance lets us help one of the most vulnerable populations that needs it the most, our kids."

ABOUT LINEUS MEDICAL

Lineus Medical is the developer of a unique, patented, break-away technology that is designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and any other type of medical tubing may be reduced as breakaway devices separate to protect the patient. More information about Lineus Medical can be found on the company website:  www.lineusmed.com or you can follow the company on Twitter or LinkedIn.

1 Dipper Study Data on File

MKG-0194 REV 00

Contact
Vance Clement
***@lineusmed.com


Source: Lineus Medical
Filed Under: Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Bad Bunny Leads 2026 Grammys Album of the Year Odds, Lady Gaga Emerges as Top Challenger
  • Metro Detroit teen Lola Winters turns viral TikTok fame into a sold-out clothing brand
  • ReedSmith® Celebrates Innovative Founders at TCVN's Survivor™ XII at SoCal Startup Day
  • The global race for next-gen precious metals recovery is accelerating: $AABB is positioning itself with it's Revolutionary rGO Gold Recovery System
  • NorthSky Celebrates One-Year Anniversary
  • Free At Last Bail Bonds Gives Back Through Major Holiday Food Distribution Efforts Across Metro Atlanta
  • Discover Elevated Living - Preview the Stunning New Townhome Collection
  • TownePlace Suites Prescott Valley, AZ Opens
  • SIX7 Introduces Olfactory Neurodesign™ — The First Fragrance System Engineered to Influence Emotion, Memory, and Desire at the Neural Level
  • GetKuwa emerging as GCC's #1 trusted online supplement marketplace as shoppers across UAE, Saudi Arabia, Kuwait, Qatar & Oman seek authenticity
  • Uk Financial Ltd Provides Investors Of Maya Preferred & Mayacat Instructions For Upcoming First Ever Listing Of Both Erc-3643 "SEC-Ready" Tokens
  • Kaufman Development and Daniel Kaufman Ventures Announce Strategic Expansion Into Data Centers and AI Infrastructure Across the United States
  • Bent Danholm Lists Modern Lakefront Estate in Winter Garden's Twinwaters Community
  • Operational Agility in High Demand: FOCUS Expands to Serve a Changing Insurance Market
  • Bahamas Import Assistant Launches Same-Day Pet Permit Service Under BAHFSA's 2024 Expansion
  • Liftoff Enterprises Launches Liftoff Spotlight,™ A Nationally Broadcast Platform Turning Conversations Into Revenue
  • From November 24th to 27th, Fuqing Invites You to Join Us at BIG 5 to Jointly Build a New Future for Middle Eastern Architecture
  • Dispelling Holiday Suicide Myth: CDC Data Shows Suicide Rates Lowest in December; International Survivors of Suicide Day Emphasizes Need for Action
  • Stratum Nutrition's OVOLUX™ Named 2025 "Collagen Ingredient of the Year" by Beauty Innovation Awards
  • Sons of Liberty Museum Unveils "America at 250" Mobile Exhibit on Veterans Day 2025

Popular on PennZone

  • New Article by Roy J. Meidinger – Examines Hidden Hidden Healthcare Kickbacks - 457
  • Mensa Foundation's New Science Program Encourages Hands-On Discovery
  • Investing in Greece: Your Definitive Real-Estate FAQ Guide
  • GitKraken Launches Insights to Help Engineering Leaders Quantify AI Impact and Improve Developer Experience
  • Blogging Pioneer Sherry Bennett Celebrates 29 Years Online - From College Blogger to Successful Entrepreneur
  • J French's #1 Album "I Don't Believe in Bad Days" Enters the Grammy Conversation
  • Crypto Betting Odds 2025: Bookmakers Review Analyzes Market Predictions and Year-End Price Lines
  • 'Wild Hermit Wellness' Has Achieved Bestseller Status in Just 2 Months Since Launch Of Organic Skincare Line
  • Bookmakers Review Releases 2028 Democratic Nominee Betting Odds: Newsom Leads Early Field
  • The OpenSSL Corporation and the OpenSSL Foundation Celebrate the Success of the Inaugural OpenSSL Conference in Prague

Similar on PennZone

  • Cuts Costs & Boosts Profits with the First Major Upgrade in 30 YEARS Replacing Rotary Lasers and Historic Clear Tube Altimeter Bubbles
  • Inframark Expands Its Specialized Automation and Intelligence Capabilities, Adds Dmytryka Jacobs Engineers
  • Upcoming Launch of Retail Crypto Cloud Mining Platform with Daily Rewards in a Transparent Revenue-Share Model: iMD Companies, Inc. Stock Symbol: ICBU
  • CRH Healthcare Opens 100th Urgent Care Clinic with Second Peachtree Immediate Care Location in Covington
  • RTC Communications Preliminarily Awarded $3.1 Million Federal BEAD Grant to Expand Fiber Broadband in Southern Indiana
  • IDCXS Exchange Founder Travels to Angola for Strategic Cooperation Talks
  • The global race for next-gen precious metals recovery is accelerating: $AABB is positioning itself with it's Revolutionary rGO Gold Recovery System
  • SIX7 Introduces Olfactory Neurodesign™ — The First Fragrance System Engineered to Influence Emotion, Memory, and Desire at the Neural Level
  • GetKuwa emerging as GCC's #1 trusted online supplement marketplace as shoppers across UAE, Saudi Arabia, Kuwait, Qatar & Oman seek authenticity
  • Operational Agility in High Demand: FOCUS Expands to Serve a Changing Insurance Market
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us